In the current month, CLGN has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CLGN average Analyst price target in the last month is 11.000.
Based on analysts' estimates, CLGN EPS is projected to reach 0.350 in FY2026Q2, following reported EPS of -2.253 in FY2026Q1. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -2.25, while Collplant Biotechnologies LtdCLGN's earnings per share (EPS) for the previous quarter was USD -2.51. EPS for the next quarter is expected at USD 0.35.